Muddassir Rizwan, NP
Nurse Practitioner · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Livwell Healthcare Solutions PC · 10 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Muddassir Rizwan’s office at (408) 821-4449 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$1,496
Medicare paid this office $1,496 for 15 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
15 Original Medicare patients in 2024. Average age 71 · Health risk score 1.20. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
The office billed $4,815, Medicare allowed $2,169 and paid $1,496; for 19 services of 7 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 15 | 19 | 71 | 1.20 | $4,815 | $1,496 |
| 2022 | 82 | 99 | 81 | 1.05 | $35,920 | $9,091 |
| 2021 | 98 | 155 | 74 | 1.02 | $32,558 | $11,273 |
| 2019 | 129 | 228 | 75 | 0.85 | $12,691 | $8,316 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2022: 2 services
| Return visit (30+ min) | 54 | $5,349 | $85 |
| Long return visit (40+ min) | 16 | $2,398 | $141 |
2021: 3 services
| Return visit (30+ min) | 56 | $5,788 | $96 |
| Short return visit (20+ min) | 33 | $2,358 | $66 |
| Insertion of needle into vein for collection of blood sample | 17 | $57 | $3 |
2019: 4 services
| Influenza vaccine split virus, preservative free | 72 | $3,105 | $43 |
| Administration of influenza virus vaccine | 77 | $1,468 | $19 |
| Return visit (30+ min) | 21 | $1,317 | $60 |
| New patient visit (30+ min) | 17 | $1,023 | $60 |
Drugs they prescribed that Part D paid
$27,305
Pharmacies billed $27,305 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 33% of their Part D prescriptions (415 of 1,268) in 2024. A higher opioid share than 9 in 10 peers; the typical nurse practitioner clinician is at 0%. Long-acting opioids: 23% of their opioid prescriptions.
1,253 generic and 15 brand-name prescriptions · $27,305 in drug cost · 39 antibiotic prescriptions to 29 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lidocaine | 27 | $8,178 | $303 |
| Acetaminophen-Codeine | 201 | $2,557 | $13 |
| Celecoxib | 90 | $2,513 | $28 |
| Morphine Sulfate Er | 38 | $1,482 | $39 |
| Gabapentin | 108 | $1,395 | $13 |
See all 21 drugs
| Lidocaine | 27 | $8,178 | $303 |
| Acetaminophen-Codeine | 201 | $2,557 | $13 |
| Celecoxib | 90 | $2,513 | $28 |
| Morphine Sulfate Er | 38 | $1,482 | $39 |
| Gabapentin | 108 | $1,395 | $13 |
| Diclofenac | 49 | $1,295 | $26 |
| Methadone | 49 | $842 | $17 |
| Cephalexin | 23 | $737 | $32 |
| Amitriptyline | 97 | $724 | $7 |
| Pregabalin | 27 | $690 | $26 |
| Baclofen | 71 | $679 | $10 |
| Naloxone | 12 | $614 | $51 |
| Lidocaine-Prilocaine | 32 | $431 | $13 |
| Duloxetine | 21 | $385 | $18 |
| Cyclobenzaprine | 58 | $311 | $5 |
| Tramadol | 87 | $260 | $3 |
| Pantoprazole | 23 | $218 | $9 |
| Hydrocodone-Acetaminophen | 28 | $121 | $4 |
| Tizanidine | 34 | $86 | $3 |
| Ibuprofen | 19 | $60 | $3 |
| Clonidine | 19 | $33 | $2 |
Year by year
| 2024 | 1,268 | 166 | 33% (415) | 1% | $27,305 |
| 2023 | 1,239 | 141 | 26% (326) | None | $30,114 |
| 2022 | 543 | 166 | 24% (132) | 3% | $16,199 |
| 2021 | 1,205 | 145 | 1% (13) | None | $95,040 |
| 2020 | 976 | 122 | 2% (18) | None | $56,220 |
| 2019 | 31 | 29 | 0% (0) | None | $1,040 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 23 drugs
| Diclofenac | 122 | $4,583 | $38 |
| Celecoxib | 90 | $3,906 | $43 |
| Gabapentin | 127 | $2,715 | $21 |
| Acetaminophen-Codeine | 163 | $1,833 | $11 |
| Naloxone | 18 | $1,485 | $82 |
| Baclofen | 75 | $1,422 | $19 |
| Lidocaine | 14 | $1,240 | $89 |
| Methadone | 55 | $1,170 | $21 |
| Cephalexin | 15 | $1,145 | $76 |
| Amitriptyline | 76 | $1,034 | $14 |
| Duloxetine | 24 | $667 | $28 |
| Lidocaine-Prilocaine | 19 | $631 | $33 |
| Cyclobenzaprine | 68 | $630 | $9 |
| Tramadol | 61 | $621 | $10 |
| Tizanidine | 54 | $613 | $11 |
| Pantoprazole | 25 | $612 | $24 |
| Morphine Sulfate Er | 20 | $453 | $23 |
| Nabumetone | 11 | $377 | $34 |
| Meloxicam | 23 | $373 | $16 |
| Clonidine | 37 | $182 | $5 |
| Ibuprofen | 16 | $164 | $10 |
| Hydrocodone-Acetaminophen | 12 | $106 | $9 |
| Trazodone | 13 | $96 | $7 |
2022: 16 drugs
| Diclofenac | 36 | $1,161 | $32 |
| Gabapentin | 38 | $925 | $24 |
| Acetaminophen-Codeine | 53 | $924 | $17 |
| Celecoxib | 16 | $789 | $49 |
| Methadone | 33 | $589 | $18 |
| Morphine Sulfate Er | 16 | $582 | $36 |
| Cyclobenzaprine | 27 | $357 | $13 |
| Tramadol | 19 | $254 | $13 |
| Losartan | 13 | $222 | $17 |
| Lorazepam | 16 | $168 | $11 |
| Amitriptyline | 15 | $159 | $11 |
| Levothyroxine | 11 | $138 | $13 |
| Ibuprofen | 13 | $92 | $7 |
| Meloxicam | 13 | $78 | $6 |
| Zolpidem | 11 | $67 | $6 |
| Clonidine | 15 | $54 | $4 |
2021: 26 drugs
| Januvia | 11 | $21,718 | $1,974 |
| Dexilant | 13 | $5,538 | $426 |
| Atorvastatin | 85 | $1,486 | $17 |
| Albuterol Sulfate Hfa | 35 | $1,194 | $34 |
| Duloxetine | 20 | $650 | $32 |
| Rosuvastatin | 13 | $630 | $48 |
| Diclofenac | 19 | $568 | $30 |
| Metformin | 98 | $537 | $5 |
| Levothyroxine | 34 | $500 | $15 |
| Lisinopril | 68 | $442 | $6 |
| Amlodipine Besylate | 51 | $386 | $8 |
| Montelukast | 22 | $288 | $13 |
| Losartan | 37 | $273 | $7 |
| Fluticasone Propionate | 21 | $249 | $12 |
| Lisinopril-Hydrochlorothiazide | 19 | $236 | $12 |
| Gabapentin | 21 | $229 | $11 |
| Omeprazole | 15 | $192 | $13 |
| Pantoprazole | 14 | $139 | $10 |
| Glipizide | 16 | $124 | $8 |
| Promethazine | 11 | $120 | $11 |
| Azithromycin | 17 | $117 | $7 |
| Hydrochlorothiazide | 26 | $116 | $4 |
| Simvastatin | 26 | $109 | $4 |
| Methylprednisolone | 13 | $97 | $7 |
| Cyclobenzaprine | 12 | $76 | $6 |
| Meloxicam | 17 | $29 | $2 |
2020: 24 drugs
| Albuterol Sulfate Hfa | 23 | $1,144 | $50 |
| Atorvastatin | 82 | $856 | $10 |
| Diclofenac | 21 | $615 | $29 |
| Metformin | 61 | $411 | $7 |
| Levothyroxine | 21 | $408 | $19 |
| Losartan | 39 | $360 | $9 |
| Lisinopril | 54 | $340 | $6 |
| Montelukast | 15 | $336 | $22 |
| Amlodipine Besylate | 54 | $326 | $6 |
| Fenofibrate | 11 | $314 | $29 |
| Amoxicillin-Clavulanate Potass | 11 | $271 | $25 |
| Triamcinolone Acetonide | 17 | $228 | $13 |
| Omeprazole | 28 | $205 | $7 |
| Fluticasone Propionate | 17 | $200 | $12 |
| Hydroxyzine | 19 | $199 | $10 |
| Lisinopril-Hydrochlorothiazide | 14 | $140 | $10 |
| Hydrochlorothiazide | 18 | $122 | $7 |
| Simvastatin | 14 | $95 | $7 |
| Methylprednisolone | 11 | $90 | $8 |
| Atenolol | 11 | $68 | $6 |
| Acetaminophen-Codeine | 11 | $58 | $5 |
| Meloxicam | 28 | $58 | $2 |
| Cyclobenzaprine | 11 | $46 | $4 |
| Furosemide | 14 | $26 | $2 |
Money from drug and device companies
$73 in 2023
A payment is not proof that care is biased.
| Medtronic | Kyphon Express II Kyphopak Tray | $73 | 3 payments
|
See all 3 published payments
| Medtronic | Meals · 2023-10-23 | Kyphon Express II Kyphopak Tray | $25 |
| Medtronic | Meals · 2023-08-22 | Kyphon Express II Kyphopak Tray | $24 |
| Medtronic | Meals · 2023-08-07 | Intellis Adaptivestim | $23 |
Professional record
- NPI
- 1174971840
- Licence
- CA NP95017417
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2016-06-02
- NPI last updated
- 2022-01-05
- NPI record certified
- 2022-01-05
This is when the NPI record was last certified, not a medical board exam.